# Mario Maggi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mario-maggi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 45,965 |
| Field | Hormonal and reproductive studies |
| h-index | 112 |
| i10-index | 615 |
| Last Known Institution | European Society for Sexual Medicine |
| OpenAlex ID | https://openalex.org/A5049759930 |
| ORCID iD | https://orcid.org/0000-0003-3267-4221 |
| Works | 1,236 |

## Researcher papers

- [Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study](https://scholariq.org/papers/hypogonadism-as-a-risk-factor-for-cardiovascular-mortality-in-men-a-meta/)
- [Multicenter Study on the Prevalence of Sexual Symptoms in Male Hypo- and Hyperthyroid Patients](https://scholariq.org/papers/multicenter-study-on-the-prevalence-of-sexual-symptoms-in-male-hypo-and/)
- [Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis](https://scholariq.org/papers/body-weight-loss-reverts-obesity-associated-hypogonadotropic-hypogonadism-a/)
- [Testosterone and Metabolic Syndrome: A Meta-Analysis Study](https://scholariq.org/papers/testosterone-and-metabolic-syndrome-a-meta-analysis-study/)
- [Type 2 diabetes mellitus and testosterone: a meta-analysis study](https://scholariq.org/papers/type-2-diabetes-mellitus-and-testosterone-a-meta-analysis-study/)
- [Sperm recovery and ICSI outcomes in men with non-obstructive azoospermia: a systematic review and meta-analysis](https://scholariq.org/papers/sperm-recovery-and-icsi-outcomes-in-men-with-non-obstructive-azoospermia-a/)
- [Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis](https://scholariq.org/papers/cardiovascular-risk-associated-with-testosterone-boosting-medications-a/)
- [Testosterone Supplementation and Sexual Function: A Meta-Analysis Study](https://scholariq.org/papers/testosterone-supplementation-and-sexual-function-a-meta-analysis-study/)
- [Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: Pathophysiology and mechanism(s) of action](https://scholariq.org/papers/tadalafil-for-the-treatment-of-lower-urinary-tract-symptoms-secondary-to-benign/)
- [The Mechanism of Action of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia](https://scholariq.org/papers/the-mechanism-of-action-of-phosphodiesterase-type-5-inhibitors-in-the-treatment/)

## Researcher topics

- [Hormonal and reproductive studies](https://scholariq.org/topics/hormonal-and-reproductive-studies/)
- [Sexual function and dysfunction studies](https://scholariq.org/topics/sexual-function-and-dysfunction-studies/)
- [Urinary Bladder and Prostate Research](https://scholariq.org/topics/urinary-bladder-and-prostate-research-2/)
- [Sexual Differentiation and Disorders](https://scholariq.org/topics/sexual-differentiation-and-disorders/)
- [Hypothalamic control of reproductive hormones](https://scholariq.org/topics/hypothalamic-control-of-reproductive-hormones/)

## Researcher university

- [European Society for Sexual Medicine](https://scholariq.org/institutions/european-society-for-sexual-medicine/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.